Fisher Asset Management
HRMY icon

Fisher Asset Management’s Harmony Biosciences HRMY Stock Holding History

Fisher Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-116
Closed -$3.8K – 1045
2023
Q3 		$3.8K Hold
116
– – ﹤0.01% 1123
2023
Q2 		$4.08K Buy
+116
New +$4K ﹤0.01% 1123

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fisher Asset Management's HRMY Position: Q4 2023 in Review

Fisher Asset Management sold out of Harmony Biosciences (HRMY) in Q4 2023, closing a stake of 116 shares — an estimated $3.8K sold.

Fisher Asset Management first reported a position in HRMY in Q2 2023 and held it in 2 quarters. The position peaked at $4.08K in Q2 2023. 221 funds tracked by Wall St. Rank hold HRMY as of Q4 2023.

  • Fisher Asset Management reported no remaining Harmony Biosciences position as of Q4 2023 after selling out during the quarter.
  • Fisher Asset Management sold 116 Harmony Biosciences shares in Q4 2023, an estimated $3.8K.
  • Fisher Asset Management first reported a position in Harmony Biosciences in Q2 2023 and held it in 2 quarters.
  • Fisher Asset Management's Harmony Biosciences position peaked at $4.08K in Q2 2023.
  • 221 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.